Drug Type Synthetic peptide |
Synonyms NPC-18521 |
Target |
Mechanism B2 receptor antagonists(Bradykinin B2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | US | 02 Aug 1996 |